Edgen Stock·Oct 08 2025, 23:25戻る
戻る
Bristol Myers Squibb Receives FDA Fast-Track for Alzheimer's Treatment Candidate
Edgen Stock·Oct 08 2025, 23:25
[1] Bristol Myers Gets FDA Fast-Track Designation for BMS-986446 in Alzheimer's (https://www.marketwatch.com/story/bristol-mye ...)[2] Bristol Myers Squibb (BMY) Gains FDA Fast Track for Alzheimer's Drug - GuruFocus (https://vertexaisearch.cloud.google.com/groun ...)[3] Prothena's Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer's Disease - Business Wire (https://vertexaisearch.cloud.google.com/groun ...)